Shenhuang granules for sepsis treatment
Part of Infections clinical trials.
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of sepsis based on current medical guidelines.
- You must be able to give your consent to participate.
- You must not have severe liver or kidney problems related to sepsis.
- You must not be expected to die within 48 hours or have very severe organ failure.
- You must not be allergic to traditional Chinese medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Shenfu injection can improve the flexibility of blood vessels in people with severe infections (sepsis or septic shock). It may help understand how to better support the heart and circulation during critical illness.
This study looks at the outcomes of people hospitalized with sepsis in China. It helps doctors understand how patients respond to treatment and what factors affect recovery.
This trial tests whether Xuebijing injection improves outcomes for adults with sepsis. It looks at how well the treatment works in everyday hospital care, not just in a controlled research setting.
This study looks at a Chinese herbal injection called Xuebijing to see if certain biomarkers can predict how well it works for sepsis patients. It may help find new ways to treat sepsis more effectively.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study tests whether acupuncture can help people at high risk for sepsis, a serious infection that can lead to organ failure. If you’re 18 or older, have had a sepsis order set put in within the last two days, and are not yet in the ICU, you may be able to join.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.